PMID- 28940139 OWN - NLM STAT- MEDLINE DCOM- 20190513 LR - 20200225 IS - 1434-9949 (Electronic) IS - 0770-3198 (Linking) VI - 38 IP - 1 DP - 2019 Jan TI - Normal serum matrix metalloproteinase-3 levels can be used to predict clinical remission and normal physical function in patients with rheumatoid arthritis. PG - 181-187 LID - 10.1007/s10067-017-3829-9 [doi] AB - This study aimed to evaluate whether normal serum matrix metalloproteinase-3 (MMP-3) levels can be used to predict clinical remission and normal physical function at a single time point when treating patients with rheumatoid arthritis (RA) in daily practice settings. Subjects were all 1321 RA patients who were treated at our hospital. The accuracy of serum MMP-3 levels was larger than those of C-reactive protein (CRP) levels for predicting clinical remission [Simplified Disease Activity Index (SDAI)